POLE and cancer: The non-negative matrix factorization algorithm has previously been used to detect the presence of mutational signatures in human cancers, including from defects in DNA mismatch repair and altered activity of the error-prone polymerase POLE (http://cancer.sanger.ac.uk/cosmic/signatures) (Alexandrov et al. 2013b).